Literature DB >> 11711005

Clinical inquiries. What laboratory monitoring is appropriate to detect adverse drug reactions in patients on cholesterol-lowering agents?

D Weismantel1, P Danis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11711005

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  4 in total

1.  Jaundice due to suspected statin hepatotoxicity: a case series.

Authors:  Ottar M Bergmann; Gudjon Kristjansson; Jon G Jonasson; Einar S Björnsson
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

Review 2.  Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.

Authors:  William Nseir; Julnar Mograbi; Murad Ghali
Journal:  Dig Dis Sci       Date:  2012-03-15       Impact factor: 3.199

3.  The effect of biliary sphincterotomy on serum cholesterol level in postcholecystectomy patients: a pilot study.

Authors:  Waleed M Alazmi; Evan L Fogel; James L Watkins; Lee McHenry; Stuart Sherman; Glen A Lehman
Journal:  Can J Gastroenterol       Date:  2007-02       Impact factor: 3.522

4.  Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.

Authors:  Saeed Kalantari; Mohammadreza Naghipour
Journal:  Adv Biomed Res       Date:  2014-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.